Clinical Trial Update: Tofacitinib for the Treatment of Alopecia Areata and Its Variants [NA]

View source ↗

Summary

A Stanford-sponsored study (NCT02312882) evaluated tofacitinib for alopecia areata and its variants. The trial status is completed and results were posted in No…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Stanford University | Conditions: Alopecia Areata, Alopecia Totalis | NA | Status: COMPLETED | Results posted: 2017-11-06